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Complications of Bone Marrow Suppression
It is not easy to distinguish the complications of bone marrow suppression from those of immunosuppression. Most immunosuppressive agents also damage bone marrow cells. Whereas the main consequences of the latter are deficiencies of red cells, polymorphs and platelets, it must be remembered that the bone marrow is to a greater or lesser extent the source of stem cells for the lymphoid system (see Loutit 1968 ) and also for the body's macrophages (Pinkett et al. 1966) .
A clear dissociation between the immunosuppressive and the myelosuppressive effect of drugs can sometimes be seen in cases of bone marrow hypoplasia or maturation arrest due to autoimmunity. Alone of the immunosuppressive agents steroid hormone is not myelotoxic. In the case shown in Fig 1 the addition of azathioprine, in appropriate dosage, actually enhanced the output of cells from the marrow, presumably by the removal of an autoimmune influence. L-asparaginase, which is a weak immunosuppressive agent, probably does not harm normal bone marrow cells, but antilymphocytic sera do have an anti-bone-marrow stem-cell effect. This is an important restriction to their use in bone marrow transplantation. All other immunosuppressive agents have a pronounced action on bone marrow cells. One reason for this coincidence is that both hmmopoiesis and specific immunization depend upon cell proliferation but this is not the whole story.
Hemorrhage is one of the outstanding complications of bone marrow suppression and is due to a lack of platelets. Concomitant liver damage may lead to a simultaneous lack of clotting factors, but this is uncommon. More important is the effect of local tissue damage or infection which, in the presence of moderate thrombocytopenia, may produce severe local hemorrhage. Such infections occur particularly in the alimentary tract. Another source of local tissue damage is the tumour which becomes necrotic following cytotoxic treatment. The newly formed vasculature gives way as a consequence of thrombocytopenia and local necrosis, and hemorrhage into multiple metastases or into a single cerebral deposit may have serious consequences.
It is possible also that the cytotoxic agents cause a significant degree of damage to the vascular endothelium. When bone marrow depression is prolonged there is a deficiency of polymorphs and probably also of macrophages, so that the resolution of ecchymoses in the tissues is prolonged. This is particularly conspicuous in the purpuric lesions which may persist in these patients without appreciable change for Treatment of thrombocytopenia by plh fusion: The normal platelet econon formation and demise of approxir platelets daily, is totally irrelevant to t platelet transfusion. Few platelets ar by haemostasis in normal circumstan during bone marrow suppression thei utilization of platelets in different wa excess of normal production. Large platelets may therefore be needed. A promptly used it should occasion no s the platelet count is increased only a i at all. Prolonged use of platelets sen recipient to foreign platelet antigens E transfusion then becomes less effe process may be somewhat diminished who are also immunosuppressed.
For this reason and because a pla fusion service is difficult and cost platelets should be given sparingly a those patients for whom recovery is hope. In our view the indication platelets is actual or threatened h rather than the result of any laboi Platelet counts are helpful if the thresh which the patient bleeds has bee assessed. The hazard of delaying plate] tration is that cerebral hemorrhage mz our experience this does not hapr absence of prior visible hemorrhage elsewhere, except where there is a local cerebral lesion. It follows that careful daily clinical examination, especially of the legs, the oral mucous membrane Both Neither and the ocular fundi, is important.
When platelets have to be given, concentrates 3 27 should be prepared from low pH acid-citrateation dextrose in what is now a fairly routine practice. Immunization demands that a search be made for compatible donors. They are most likely to be found among the patient's family and in these ed has been circumstances the use of a blood cell separator, whereby many units of platelets can be obtained from one donor, is invaluable. atelet transny, i.e. the Leukocyte deficiency: Although leukopenia, which nately 1011 includes both polymorph and macrophage the need for deficiences, predisposes to infection a transient e consumed shortage of leukocytes is seldom important and ces whereas may be quite without symptoms. Furthermore the re may be a commonest symptoms encountered during methoys vastly in trexate or 6-mercaptopurine treatment, namely numbers of inflammation and ulceration of the mucosa of the is these are mouth or anal and vulval regions, are probably ,urprise that due to the direct action of the drug on the little or not epithelial cells. Table 1 shows that mucositis and bone marrow depression after a standard course isitizes the of methotrexate are, in fact, not often associatedand platelet less frequently, indeed, than would be expected to ctive. This occur by chance. in patients
As we have seen, almost any micro-organisms may take advantage of a leukopenic host; they do ttelet transso in circumstances where diagnosis may be tly to run, unusually difficult. The lack of leukocytes robs a nd only to lesion of some characteristic features. Red and a realistic painful skin lesions caused by staphylococci lack for giving pus but the organism can be recovered, if necesiemorrhage sary, by aspiration of tissue fluid with a fine ratory test. needle. In chest infections the sputum is not iold level at purulent and in urinary infections pus cells are ,n recently absent; this circumstance may obscure the let adminis-significance of the bacteria present, especially if ay occur. In two or more different organisms are cultured. pen in the Even the presence of meningitis may not be easily appreciated in examining a CSF without polymorphs. The same considerations apply to post-mortem examination where both macroscopic evidence, such as a septic spleen, and microscopic evidence in the form of leukocyte infiltration may disguise the true state of affairs at death. Table 2 shows an analysis of causes of death in 46 patients treated with myelosuppressive agents or having primary bone marrow aplasia. These figures are influenced by many factors including the attitude of mind of the physicians concerned. Most of these patients, in fact, died after antineoplastic treatment had been abandoned. One htemorrhagic death four years ago in a case of leukw,mia shortly after admission might nowadays have been prevented. Another death, in which hLemorrhage played a part, resulted from the too-successful treatment of multiple metastases which simultaneously underwent hmmorrhagic necrosis, coincident with only a moderate degree of thrombocytopenia.
It is worth noting that among the cases in children were two virus infections, varicella and generalized herpes, but that at this age bacterial septicamia was less common. Reluctance to perform blood cultures does not wholly account for the difference between children and adults.
There was at least one mystery death, a 6-yearold child who developed convulsions during a phase of leukopenia. No bacterial, toxic or biochemical cause was evident and a careful post-mortem showed no cerebral or other lesion. An overwhelming virus infection seems the most likely cause.
Gram-negative bacilli were grown in all but one of the cases of fatal septicemia. Except for one pseudomonas these organisms were probably endogenous rather than acquired. The coexistence of two or more organisms in 4 cases raises problems of treatment. If a narrowspectrum antibiotic is used against a single sensitive organism, such as a staphylococcus, this may be rapidly replaced by a Gram-negative bacterium or by candida. Thus there is a strong argument for using broad-spectrum antibiotics, with or without antifungal agents, whenever serious infection is clinically diagnosed, and also for the prophylactic use of unabsorbable antibiotics and anti-fungal agents. The difficulties are that the antibiotics may be poorly tolerated or may be absorbed in dangerous degree from ulcerated areas in the intestine; they do not eradicate potential pathogens especially from areas such as the perineum or from pre-existing pockets of local infection, and they may even encourage the proliferation ofresistant organisms, thus creating a new hazard. The problem requires full clinical trial.
An alternative or adjuvant method of treatment is the provision of fresh white cells which in practice involves the use of a blood cell separator. From a normal donor it is only possible to remove about 2 x 109 cells at a time and the benefit is probably only marginal although there may be circumstances, especially perhaps in children, where even this small number of cells may be valuable. In general, however, donors with chronic granulocytic leukvmia (CGL) are preferred because of the greater cell yield (c.1011 cells) and because many of the cells continue to proliferate in the circulation and bone marrow for days or even weeks. There is a slight risk that the disease of CGL will be conveyed to the recipient and a rather greater hazard of graft-against-host reactions. These are mediated by the viable lymphocytes which may also be present in platelet concentrates; the risk is in proportion to the state of immunodepression of the recipient, the number of viable lymphocytes transferred, and the histocompatibility relationship of host and donor. A full scale graft-against-host reaction is probably not to be expected but the chance of impairment of bone marrow and lymphoid function by a minor reaction cannot be ignored. Irradiation of all cell suspensions for cases at risk is a simple and effective preventive measure. It is even possible to irradiate cells in circuit between donor and recipient and it can be shown that such an irradiation to a dose of 1,500 rad does not impair the viability of the granulocytes and even permits some continued proliferation of myelocytes.
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Tumour Development Following Immunosuppression
It is now generally accepted that most tumours in experimental animals have new antigens which are not present in the host tissues and are therefore able to elicit an immune response. As a rule, all tumours induced by a particular virus have common antigens, so that immunization with an oncogenic virus will protect animals against transplants of syngeneic tumours induced by the same virus, but not against tumours induced by other viruses.
